Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads

European Journal of Medicinal Chemistry

Volumn 46, Issue 3, 2011, Pages 851-859

  Vadivelan, S ^a,c   Deeksha, T N ^d   Arun, S ^a   MacHiraju, Pavan Kumar ^a   Gundla, Rambabu ^a   Sinha, Barij Nayan ^b   Jagarlapudi, Sarma A R P ^a  

^a GVK BIOSCIENCES PVT LTD   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

^c EGS Pillay Engineering College   (India)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

3D QSAR; Docking; HIV 1; HypoGen; Pharmacophore; Reverse transcriptase inhibitors

Indexed keywords

RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; NONHUMAN; PHARMACOPHORE;

ANTI-HIV AGENTS; DRUG DESIGN; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79951682045     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.12.022     Document Type: Article

References (24)

1. A.S. Fauci The human immunodeficiency virus: infectivity and mechanisms of pathogenesis Science 239 1988 617 622 (Pubitemid 18066223)
2. M.T. Makhija, R.T. Kasliwal, V.M. Kulkarni, and N. Neamati De novo design and synthesis of HIV-1 integrase inhibitors Bioorg. Med. Chem. 12 2004 2317 2333 (Pubitemid 38471716)
3. D. Warnke, J. Barreto, and Z. Temesgen Antiretroviral drugs J. Clin. Pharmacol. 47 2007 1570 1579
4. K. Roy, and J.T. Leonard QSAR modeling of HIV-1 reverse transcriptase inhibitor 2-amino-6-arylsulfonylbenzonitriles and congeners using molecular connectivity and E-state parameters Bioorg. Med. Chem. 12 2004 745 754 (Pubitemid 38169262)
5. K. Brinkman, H.J. ter Hofstede, D.M. Burger, J.A. Smeitink, and P.P. Koopmans Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway AIDS 12 1998 1735 1744 (Pubitemid 28454438)
6. F.M. Hecht, R.M. Grant, C.J. Petropoulos, B. Dillon, M.A. Chesney, H. Tian, N.S. Hellmann, N.I. Bandrapalli, L. Digilio, B. Branson, and J.O. Kahn Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors N. Engl. J. Med. 339 1998 307 311 (Pubitemid 28366419)
7. A.C. Gaudio, and C.A. Montanari HEPT derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase: QSAR studies agree with the crystal structures J. Comput. Aided Mol. Des. 16 2002 287 295 (Pubitemid 35174569)
8. P. Pungpo, and S. Hannongbua Three-dimensional quantitative structure-activity relationships study on HIV-1 reverse transcriptase inhibitors in the class of dipyridodiazepinone derivatives, using comparative molecular field analysis J. Mol. Graph. Model. 18 2000 581 590 (Pubitemid 32072138)
9. S. Gayen, B. Debnath, S. Samanta, and T. Jha QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters Bioorg. Med. Chem. 12 2004 1493 1503 (Pubitemid 38296540)
10. P.A. Keller, C. Birch, S.P. Leach, D. Tyssen, and R. Griffith Novel pharmacophore-based methods reveal gossypol as a reverse transcriptase inhibitor J. Mol. Graph. Model. 21 2003 365 373 (Pubitemid 36120770)
11. J.M.J. Tronchet, M. Grigorov, N. Dolatshahi1, F. Moriaud, and J. Weber A QSAR study confirming the heterogeneity of the HEPT derivative series regarding their interaction with HIV reverse transcriptase Eur. J. Med. Chem. 32 1997 279 299
12. M.L. Barreca, A. Carotti, A. Carrieri, A. Chimirri, A.M. Monforte, M. Pellegrini Calace, and A. Rao Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) Bioorg. Med. Chem. 7 1999 2283 2292 (Pubitemid 30122730)
13. S. Balaji, C. Karthikeyan, N.S. Moorthy, and P. Trivedi QSAR modelling of HIV-1 reverse transcriptase inhibition by benzoxazinones using a combination of P-VSA and pharmacophore feature descriptors Bioorg. Med. Chem. Lett. 14 2004 6089 6094 (Pubitemid 39531278)
14. V. Ravichandran, V.K. Mourya, and R.K. Agrawal QSAR prediction of HIV-1 reverse transcriptase inhibitory activity of benzoxazinone derivatives Internet Electron. J. Mol. Des. 6 2007 363 374
15. V. Ravichandran, V.K. Mourya, and R.K. Agrawal QSAR modeling of HIV-1 reverse transcriptase inhibitory activity with PETT derivatives Digest J. Nanomat. Biostruct 3 2008 9 17
16. A.R. Leach, and V.J. Gillet An Introduction to Chemoinformatics 2003 Kluwer Academic Publishers The Netherlands, Dordrecht
17. D. Wilton, and P.J. Willett Comparison of ranking methods for virtual screening in lead- discovery programs J. Chem. Inf. Comput. Sci. 43 2003 469 474
18. A. Bak, and J. Polanski A 4D-QSAR study on anti-HIV HEPT analogues Bioorg. Med. Chem. 14 2006 273 279 (Pubitemid 41635489)
19. Catalyst, Version 4.11 2010 Accelrys Inc San Diego, CA 92121, USA
20. MediChem Database 2010 GVK Biosciences Private Limited Hyderabad, India
21. 2, Version 4.11 2010 Accelrys Inc San Diego, CA 92121, USA
22. Maestro, Version 1.0.9113 2010 Schrodinger, L.L.C. New York
23. Glide Version 9.1 2010 Schrodinger, L.L.C. New York
24. A. Spallarossa, S. Cesarini, A. Ranise, M. Ponassi, T. Unge, and M. Bolognesi Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors Biochem. Biophys. Res. Commun. 365 2008 764 770 (Pubitemid 350234856)